Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-08-16

FDA Approved: IPRATROPIUM BROMIDE — Original Application (Amneal Pharmaceuticals NY LLC)

View source ↗

Summary

FDA approved the original ANDA for ipratropium bromide as a generic inhalation product from Amneal Pharmaceuticals NY LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IPRATROPIUM BROMIDE (IPRATROPIUM BROMIDE)

Snippet

ORIG AP for IPRATROPIUM BROMIDE (IPRATROPIUM BROMIDE)